ConductScience.org, home

Paper3929255

Interleukin 2 receptor gene expression in normal human T lymphocytes.

Leonard WJ and 4 others. Proc Natl Acad Sci U S A, 1985. Cited by 204 papers, by iCite.

Cite this record

ConductScience Library. Interleukin 2 receptor gene expression in normal human T lymphocytes. Papers, record 3929255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3929255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin 2 receptor gene expression in normal human T lymphocytes.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
204
iCite
Relative citation ratio, by iCite
3.65
iCite
Revised in PubMed
2020-12-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leonard WJW J
2Krönke MM
3Peffer NJN J
4Depper JMJ M
5Greene WCW C

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
Receptors, ImmunologicMajor topic
T-LymphocytesMajor topic
Cell Division
Cell Nucleus
DNA
Gene Expression Regulation
HLA Antigens
HLA-B7 Antigen
Humans
Lymphocyte Activation
Poly A
RNA, Messenger
Receptors, Interleukin-2
Time Factors
Transcription, Genetic

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1181845Selective in vitro growth of T lymphocytes from normal human bone marrows.Science1976https://conductscience.org/library/papers/181845PubMed
26090948Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.Nature1984https://conductscience.org/library/papers/6090948PubMed
3518835Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.Biochemistry1979https://conductscience.org/library/papers/518835PubMed
47000676T-cell growth factor.Immunol Rev1980https://conductscience.org/library/papers/7000676PubMed
56975347T cell growth factor receptors. Quantitation, specificity, and biological relevance.J Exp Med1981https://conductscience.org/library/papers/6975347PubMed
66090949Molecular cloning of cDNA encoding human interleukin-2 receptor.Nature1984https://conductscience.org/library/papers/6090949PubMed
76092466Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.J Immunol1984https://conductscience.org/library/papers/6092466PubMed
86436815Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6436815PubMed
96096720Cloning, sequence and expression of human interleukin-2 receptor.Nature1984https://conductscience.org/library/papers/6096720PubMed
102981876
The human receptor for T-cell growth factor. Evidence for variable post-translational processing, phosphorylation, sulfation, and the ability of precursor forms of the receptor to bind T-cell growth factor.
J Biol Chem1985https://conductscience.org/library/papers/2981876PubMed
116335665Transcriptional modulation of human T-cell growth factor gene by phorbol ester and interleukin 1.Biochemistry1984https://conductscience.org/library/papers/6335665PubMed
122989408Sequential expression of genes involved in human T lymphocyte growth and differentiation.J Exp Med1985https://conductscience.org/library/papers/2989408PubMed
132989411Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells.J Exp Med1985https://conductscience.org/library/papers/2989411PubMed
146176879Variety in the level of gene control in eukaryotic cells.Nature1982https://conductscience.org/library/papers/6176879PubMed
156815536A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.Nature1982https://conductscience.org/library/papers/6815536PubMed
166312838A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.Anal Biochem1983https://conductscience.org/library/papers/6312838PubMed
176606011Transient expression of interleukin 2 receptors. Consequences for T cell growth.J Exp Med1983https://conductscience.org/library/papers/6606011PubMed
186417659Characterization of the human receptor for T-cell growth factor.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6417659PubMed
196327813Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells.J Immunol1984https://conductscience.org/library/papers/6327813PubMed
206330200Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells.J Immunol1984https://conductscience.org/library/papers/6330200PubMed

See all 24 referencesDownload CSV of references

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.

PMIDTitleJournalYearIn PapersSource
38539570Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy.Cancers (Basel)2024https://conductscience.org/library/papers/38539570PubMed
37353767Unsolved mystery of Fas: mononuclear cells may have trouble dying in patients with Sjögren's syndrome.BMC Immunol2023https://conductscience.org/library/papers/37353767PubMed
34566410A Computational Approach to Modeling an Antagonistic Angiogenic VEGFR1-IL2 Fusion Protein for Cancer Therapy.Bioinform Biol Insights2021https://conductscience.org/library/papers/34566410PubMed
34003116Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist.Elife2021https://conductscience.org/library/papers/34003116PubMed
33504055Transcriptional Differences between Canine Cutaneous Epitheliotropic Lymphoma and Immune-Mediated Dermatoses.Genes (Basel)2021https://conductscience.org/library/papers/33504055PubMed
32187647A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis.Immunology2020https://conductscience.org/library/papers/32187647PubMed
31940588Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.J Immunother Cancer2020https://conductscience.org/library/papers/31940588PubMed
30992377Select sequencing of clonally expanded CD8+ T cells reveals limits to clonal expansion.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30992377PubMed
30089912Biology and regulation of IL-2: from molecular mechanisms to human therapy.Nat Rev Immunol2018https://conductscience.org/library/papers/30089912PubMed
29443657IL-2 and Beyond in Cancer Immunotherapy.J Interferon Cytokine Res2018https://conductscience.org/library/papers/29443657PubMed
29038115The Common Cytokine Receptor γ Chain Family of Cytokines.Cold Spring Harb Perspect Biol2018https://conductscience.org/library/papers/29038115PubMed
28927416Tumor-related interleukins: old validated targets for new anti-cancer drug development.Mol Cancer2017https://conductscience.org/library/papers/28927416PubMed
28854172Discovery of stimulation-responsive immune enhancers with CRISPR activation.Nature2017https://conductscience.org/library/papers/28854172PubMed
27471638Role of IL-2 in cancer immunotherapy.Oncoimmunology2016https://conductscience.org/library/papers/27471638PubMed
23352221Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.Immunity2013https://conductscience.org/library/papers/23352221PubMed
22013128Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.J Immunol2011https://conductscience.org/library/papers/22013128PubMed
21113743Immunotoxicity monitoring of hospital staff occupationally exposed to cytostatic drugs.Pathol Oncol Res2011https://conductscience.org/library/papers/21113743PubMed
19880579hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation.Int Immunol2009https://conductscience.org/library/papers/19880579PubMed
19340848Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice.J Gene Med2009https://conductscience.org/library/papers/19340848PubMed
18780166The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.J Clin Immunol2008https://conductscience.org/library/papers/18780166PubMed

See all 56 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL2RB3560PubTator's text mininghttps://conductscience.org/library/genes/3560

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3929255

GET https://conductscience.org/api/papers/v1/3929255/references?page=2